Ally Biotech with Vice President of Business Development Chef Francis Baczek today on Blunt Business only on The Cannabis Radio. Our next guest’s company brings next-generation oral delivery technologies to the cannabinoid market, empowering brands to become industry game-changers. Ally Biotech offers product development services and manufacturing-ready, water-soluble Lipofusion™ THC that can be utilized as a raw ingredient in powder or liquid form in a variety of products. There are manufacturing methods used like liposomal technology and bio-mimicking processes that create a more natural pathway in the body for improving absorption. With liposomal technology, safety is more defined than nanotechnology. Nanotechnology fractures the compounds into tiny (nanometer-sized) particles, with the goal of the compounds’ being so small they enter the bloodstream without degradation in the liver. The issue with nano-technology is understanding the pharmacokinetics of the nano-particles and how they truly absorb, distribute, metabolize and excrete (ADME) in the body. We talk about the Lipofusion™ delivery technology.